SARS-CoV-2 Displays a Suboptimal Codon Usage Bias for Efficient Translation in Human Cells Diverted by Hijacking the tRNA Epitranscriptome

被引:0
|
作者
Eldin, Patrick [1 ]
David, Alexandre [2 ,3 ]
Hirtz, Christophe [3 ]
Battini, Jean-Luc [1 ]
Briant, Laurence [1 ]
机构
[1] Univ Montpellier, Inst Rech Infectiol Montpellier IRIM, CNRS, UMR 9004, 1919 Route Mende, F-34293 Montpellier, France
[2] INSERM, U1191, Inst Genom Fonct IGF, 141 Rue Cardonille, F-34000 Montpellier, France
[3] Univ Montpellier, Inst Regenerat Med & Biotherapy IRMB Plateforme Pr, Inst Neurosci Montpellier INM, CHU Montpellier,INSERM,CNRS, 298 Rue Truel, F-34090 Montpellier, France
关键词
SARS-CoV-2; codon usage; tRNA; epitranscriptome; translation; POLYMERASE-III TRANSCRIPTION; MESSENGER-RNA; ADAPTATION INDEX; CLUSTER-ANALYSIS; EFFECTIVE NUMBER; GENES; PROTEIN; GENOME; ABUNDANCE; CANCER;
D O I
10.3390/ijms252111614
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Codon bias analysis of SARS-CoV-2 reveals suboptimal adaptation for translation in human cells it infects. The detailed examination of the codons preferentially used by SARS-CoV-2 shows a strong preference for Lys(AAA), Gln(CAA), Glu(GAA), and Arg(AGA), which are infrequently used in human genes. In the absence of an adapted tRNA pool, efficient decoding of these codons requires a 5-methoxycarbonylmethyl-2-thiouridine (mcm(5)s(2)) modification at the U-34 wobble position of the corresponding tRNAs (tLys(UUU); tGln(UUG); tGlu(UUC); tArg(UCU)). The optimal translation of SARS-CoV-2 open reading frames (ORFs) may therefore require several adjustments to the host's translation machinery, enabling the highly biased viral genome to achieve a more favorable "Ready-to-Translate" state in human cells. Experimental approaches based on LC-MS/MS quantification of tRNA modifications and on alteration of enzymatic tRNA modification pathways provide strong evidence to support the hypothesis that SARS-CoV-2 induces U-34 tRNA modifications and relies on these modifications for its lifecycle. The conclusions emphasize the need for future studies on the evolution of SARS-CoV-2 codon bias and its ability to alter the host tRNA pool through the manipulation of RNA modifications.
引用
收藏
页数:26
相关论文
共 50 条
  • [41] SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients
    Pontelli, Marjorie C.
    Castro, Italo A.
    Martins, Ronaldo B.
    La Serra, Leonardo
    Veras, Flavio P.
    Nascimento, Daniele C.
    Silva, Camila M.
    Cardoso, Ricardo S.
    Rosales, Roberta
    Gomes, Rogerio
    Lima, Thais M.
    Souza, Juliano P.
    Vitti, Brenda C.
    Caetite, Diego B.
    de Lima, Mikhael H. F.
    Stumpf, Spencer D.
    Thompson, Cassandra E.
    Bloyet, Louis-Marie
    Toller-Kawahisa, Juliana E.
    Giannini, Marcela C.
    Bonjorno, Leticia P.
    Lopes, Maria I. F.
    Batah, Sabrina S.
    Li Siyuan
    Luppino-Assad, Rodrigo
    Almeida, Sergio C. L.
    Oliveira, Fabiola R.
    Benatti, Maira N.
    Pontes, Lorena L. F.
    Santana, Rodrigo C.
    Vilar, Fernando C.
    Auxiliadora-Martins, Maria
    Shi, Pei-Yong
    Cunha, Thiago M.
    Calado, Rodrigo T.
    Alves-Filho, Jose C.
    Zamboni, Dario S.
    Fabro, Alexandre T.
    Louzada-Junior, Paulo
    Oliveira, Rene D. R.
    Whelan, Sean P. J.
    Cunha, Fernando Q.
    Arruda, Eurico
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2022, 14 (04)
  • [42] SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates
    Li, Tingting
    Zheng, Qingbing
    Yu, Hai
    Wu, Dinghui
    Xue, Wenhui
    Xiong, Hualong
    Huang, Xiaofen
    Nie, Meifeng
    Yue, Mingxi
    Rong, Rui
    Zhang, Sibo
    Zhang, Yuyun
    Wu, Yangtao
    Wang, Shaojuan
    Zha, Zhenghui
    Chen, Tingting
    Deng, Tingting
    Wang, Yingbin
    Zhang, Tianying
    Chen, Yixin
    Yuan, Quan
    Zhao, Qinjian
    Zhang, Jun
    Gu, Ying
    Li, Shaowei
    Xia, Ningshao
    EMERGING MICROBES & INFECTIONS, 2020, 9 (01) : 2076 - 2090
  • [43] Antihypertensive drug treatment and susceptibility to SARS-CoV-2 infection in human PSC-derived cardiomyocytes and primary endothelial cells
    Iwanski, Jessika
    Kazmouz, Sobhi G.
    Li, Shuaizhi
    Stansfield, Ben
    Salem, Tori T.
    Perez-Miller, Samantha
    Kazui, Toshinobu
    Jena, Lipsa
    Uhrlaub, Jennifer L.
    Lick, Scott
    Nikolich-Zugich, Janko
    Konhilas, John P.
    Gregorio, Carol C.
    Khanna, May
    Campos, Samuel K.
    Churko, Jared M.
    STEM CELL REPORTS, 2021, 16 (10): : 2459 - 2472
  • [44] Infection of Human Cells by SARS-CoV-2 and Molecular Overview of Gastrointestinal, Neurological, and Hepatic Problems in COVID-19 Patients
    Rahban, Mahdie
    Stanek, Agata
    Hooshmand, Amirreza
    Khamineh, Yasaman
    Ahi, Salma
    Kazim, Syed Naqui
    Ahmad, Faizan
    Muronetz, Vladimir
    Samy Abousenna, Mohamed
    Zolghadri, Samaneh
    Saboury, Ali A.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
  • [45] A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells
    Garreta, Elena
    Prado, Patricia
    Stanifer, Megan L.
    Monteil, Vanessa
    Marco, Andres
    Ullate-Agote, Asier
    Moya-Rull, Daniel
    Vilas-Zornoza, Amaia
    Tarantino, Carolina
    Pablo Romero, Juan
    Jonsson, Gustav
    Oria, Roger
    Leopoldi, Alexandra
    Hagelkruys, Astrid
    Gallo, Maria
    Gonzalez, Federico
    Domingo-Pedrol, Pere
    Gavalda, Aleix
    Hurtado del Pozo, Carmen
    Hasan Ali, Omar
    Ventura-Aguiar, Pedro
    Maria Campistol, Josep
    Prosper, Felipe
    Mirazimi, Ali
    Boulant, Steeve
    Penninger, Josef M.
    Montserrat, Nuria
    CELL METABOLISM, 2022, 34 (06) : 857 - +
  • [46] The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells
    Rothan, Hussin A.
    Stone, Shannon
    Natekar, Janhavi
    Kumari, Pratima
    Arora, Komal
    Kumar, Mukesh
    VIROLOGY, 2020, 547 : 7 - 11
  • [47] Gene Expression Profiling Reveals the Shared and Distinct Transcriptional Signatures in Human Lung Epithelial Cells Infected With SARS-CoV-2, MERS-CoV, or SARS-CoV: Potential Implications in Cardiovascular Complications of COVID-19
    Jha, Prabhash Kumar
    Vijay, Aatira
    Halu, Arda
    Uchida, Shizuka
    Aikawa, Masanori
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 7
  • [48] Deep learning-assisted pipeline for Virtual Screening of ligand compound databases: Application on inhibiting the entry of SARS-CoV-2 into human cells
    Mylonas, Stelios
    Axenopoulos, Apostolos
    Katsamakas, Sotiris
    Gkekas, Ioannis
    Stamatopoulos, Kostas
    Petrakis, Spyros
    Daras, Petros
    2020 IEEE 20TH INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOENGINEERING (BIBE 2020), 2020, : 132 - 139
  • [49] Oral Epithelial Cells Expressing Low or Undetectable Levels of Human Angiotensin-Converting Enzyme 2 Are Susceptible to SARS-CoV-2 Virus Infection In Vitro
    Ebraham, Laith
    Xu, Chuan
    Wang, Annie
    Hernandez, Cyril
    Siclari, Nicholas
    Rajah, Divino
    Walter, Lewins
    Marras, Salvatore A. E.
    Tyagi, Sanjay
    Fine, Daniel H.
    Daep, Carlo Amorin
    Chang, Theresa L.
    PATHOGENS, 2023, 12 (06):
  • [50] Characterization of SARS-CoV-2 replication in human H1299/ACE2 cells: A versatile and practical infection model for antiviral research and beyond
    Salgado-Benvindo, Clarisse
    Tas, Ali
    Zevenhoven-Dobbe, Jessika C.
    van der Meer, Yvonne
    Sidorov, Igor A.
    Leijs, Anouk A.
    Wanningen, Patrick
    Gelderloos, Anne T.
    van Kasteren, Puck B.
    Snijder, Eric J.
    van Hemert, Martijn J.
    ANTIVIRAL RESEARCH, 2024, 227